STOCK TITAN

U S Physical Therapy SEC Filings

USPH NYSE

Welcome to our dedicated page for U S Physical Therapy SEC filings (Ticker: USPH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

U.S. Physical Therapy filings document the public-company record for a Nevada-incorporated operator of outpatient physical therapy clinics and provider of industrial injury prevention services. Its 8-K reports cover operating results, conference-call transcripts, investor presentations, dividends, acquisitions, strategic alliances, and material financing agreements, including amended senior credit facilities.

Proxy materials describe annual meeting matters such as director elections, advisory executive compensation votes, auditor ratification, board governance, and equity-based compensation arrangements. Other disclosures address common stock, restricted stock units, dividend equivalents, executive compensation plans, leadership changes, reimbursement and operating risks, and the company’s physical therapy and industrial injury prevention business model.

Rhea-AI Summary

Swanson Regg E. reported acquisition or exercise transactions in this Form 4 filing.

U.S. Physical Therapy director Regg E. Swanson reported a stock award and updated holdings. He received a grant of 2,306 shares of common stock at a reported price of $0.00 per share as a compensation-related award.

The filing notes this corrects a prior report that had used $61.61 as the transaction price. Following the award, Swanson holds 15,492 shares directly and 7,596 shares indirectly through the Regg E. Swanson Revocable Trust, where he is beneficiary and trustee.

The 2,306 restricted shares vest in tranches: 1,153 shares on August 20, 2026, 576 shares on November 20, 2026, and 577 shares on March 6, 2027, if he remains a director on those dates.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Motsenbocker Anne reported acquisition or exercise transactions in this Form 4 filing.

U.S. Physical Therapy director Anne Motsenbocker received an equity grant of 2,306 shares of common stock on May 19, 2026. The shares were granted at $0.00 as restricted stock under the company’s Amended and Restated 2003 Stock Incentive Plan, bringing her direct holdings to 9,812 shares.

The restrictions lapse in stages if she continues as a director: 1,153 shares on August 20, 2026, 576 shares on November 20, 2026, and 577 shares on March 6, 2027.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Minan Peter Francis reported acquisition or exercise transactions in this Form 4 filing.

U.S. Physical Therapy director Peter Francis Minan received a grant of 2,306 shares of common stock as a stock award, with a corrected transaction price of $0.00 per share. This award was issued as restricted stock under the company’s Amended and Restated 2003 Stock Incentive Plan.

Following the grant, he holds 2,431 shares directly. The restrictions on these 2,306 shares lapse in stages: 1,153 shares on August 20, 2026, 576 shares on November 20, 2026, and 577 shares on March 6, 2027, provided he is a director on those dates.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Harris Bernard A Jr reported acquisition or exercise transactions in this Form 4 filing.

U S Physical Therapy director Bernard A. Harris Jr. received a grant of 2,306 shares of common stock as a restricted stock award. The grant was made at a reported transaction price of $0.00 per share and increased his direct holdings to 20,914 shares.

These 2,306 restricted shares vest in stages under the company’s Amended and Restated 2003 Stock Incentive Plan: 1,153 shares on August 20, 2026, 576 shares on November 20, 2026, and 577 shares on March 6, 2027, if he remains a director on those dates.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Gilmartin Kathleen A reported acquisition or exercise transactions in this Form 4 filing.

U.S. Physical Therapy director Kathleen A. Gilmartin received an award of 2,306 shares of Common Stock as a stock grant. The award was granted at a price of $0.00 per share as compensation, not an open-market purchase or sale.

After this grant, she holds 27,092 shares directly. The grant is in the form of restricted stock under the Company Amended and Restated 2003 Stock Incentive Plan, with portions scheduled to vest on specified future dates if she continues serving as a director.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Motsenbocker Anne reported acquisition or exercise transactions in this Form 4 filing.

U S Physical Therapy director Anne Motsenbocker received a grant of 2,306 shares of common stock at $61.61 per share as equity compensation. This award increased her direct holdings to 9,812 shares of the company’s stock.

The 2,306 granted shares are restricted stock. According to the terms, restrictions lapse as to 1,153 shares on August 20, 2026, 576 shares on November 20, 2026, and 577 shares on March 6, 2027, if she remains a director on those dates.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Swanson Regg E. reported acquisition or exercise transactions in this Form 4 filing.

U.S. Physical Therapy director Regg E. Swanson reported an equity award of company stock. He received a grant of 2,306 shares of common stock as restricted stock at a reference price of $61.61 per share, increasing his direct holdings to 15,492 shares.

The footnotes state these 2,306 restricted shares were granted under the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions are scheduled to lapse on August 20, 2026 for 1,153 shares, November 20, 2026 for 576 shares, and March 6, 2027 for 577 shares, if he remains a director on those dates. He also has 7,596 shares held indirectly through the Regg E. Swanson Revocable Trust, where he is beneficiary and trustee.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Minan Peter Francis reported acquisition or exercise transactions in this Form 4 filing.

U.S. Physical Therapy director Peter Francis Minan received a grant of 2,306 shares of Common Stock as restricted stock. The award is valued at $61.61 per share for reporting purposes and increases his direct holdings to 2,431 shares.

According to the grant terms, restrictions lapse as to 1,153 shares on August 20, 2026, 576 shares on November 20, 2026, and 577 shares on March 6, 2027, if he continues to serve as a director on those dates.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Harris Bernard A Jr reported acquisition or exercise transactions in this Form 4 filing.

U.S. Physical Therapy director Bernard A. Harris Jr. received 2,306 shares of common stock as a restricted stock award. The shares were granted at a reference price of $61.61 per share under the Company Amended and Restated 2003 Stock Incentive Plan. Following this grant, he directly holds 20,914 shares.

The award vests over time if he continues serving as a director. Restrictions lapse on 1,153 shares on August 20, 2026, 576 shares on November 20, 2026, and 577 shares on March 6, 2027, conditioned on his board service on those dates.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Gilmartin Kathleen A reported acquisition or exercise transactions in this Form 4 filing.

U.S. Physical Therapy director Kathleen A. Gilmartin received an award of 2,306 shares of Common Stock, valued at $61.61 per share. This restricted stock grant increases her direct holdings to 27,092 shares. Restrictions lapse in stages through March 6, 2027, contingent on continued board service.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many U S Physical Therapy (USPH) SEC filings are available on StockTitan?

StockTitan tracks 74 SEC filings for U S Physical Therapy (USPH), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for U S Physical Therapy (USPH)?

The most recent SEC filing for U S Physical Therapy (USPH) was filed on May 28, 2026.